Schedule 14 Transitional provisions relating to the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025F1

1. 1Interpretation
2. 2Application of the old rules to the authorisation etc of existing clinical trials
3. 3Application of Good Clinical Practice to old rules clinical trials
4. 4Pharmacovigilance in respect of old rules clinical trials
5. 5Manufacture and importation of investigational medicinal products used in old rules clinical trials
6. 6Labelling of investigational medicinal products used in old rules clinical trials
7. 7Enforcement etc